Effects of Eprosartan on Diastolic Function and Neurohormones in Patients with Hypertension and Diastolic Dysfunction

Autor: Dirk J. van Veldhuisen, Adriaan A. Voors, Thijs W. M. Plokker, Richard G. Vijn, Jasper W. L. Hartog, W. Jaarsma, Ruud M.A. van de Wal, Yoran M. Hummel

Publikováno v: Cardiovascular Drugs and Therapy
Cardiovascular Drugs and Therapy, 24(1), 33-40. SPRINGER

To compare the effects of an angiotensin receptor blocker(ARB)-based regimen versus a non-ARB based regimen on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.97 patients with a systolic blood pressure (SB

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b3ae83dd408c8acb384b4150c5aa14
https://doi.org/10.1007/s10557-010-6221-4

High prevalence of microalbuminuria in chronic heart failure patients

Autor: H.W.Thijs Plokker, Dirk J. Lok, Adriaan A. Voors, Dirk J. van Veldhuisen, Wiek H. van Gilst, Tom D. J. Smilde, Folkert W. Asselbergs, Ruud M.A. van de Wal

Publikováno v: JOURNAL OF CARDIAC FAILURE, 11(8), 602-606. Churchill Livingstone

Background: Microalbuminuria is associated with increased risk for cardiovascular morbidity and mortality. However, the relation between microalbuminuria and chronic heart failure has not been well described yet. In this cross-sectional study, we aim

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b09a2adb23ee7b12c344ad085a7365
https://doi.org/10.1016/j.cardfail.2005.05.007

Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology

Autor: Dirk J. van Veldhuisen, Adriaan A. Voors, Ruud M.A. van de Wal, Wiek H. van Gilst

Publikováno v: European Heart Journal. 26:2361-2367

Both angiotensin-converting enzyme (ACE)-inhibitors and angiotensin receptor blockers (ARBs) interfere with the activity of the renin–angiotensin system (RAS) in a different way. Theoretically, one might expect beneficial effects when they are used

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1be95ba3f69a58e95ff559f5b0ddc36e
https://doi.org/10.1093/eurheartj/ehi454

Plasma matrix metalloproteinase-9 and ACE-inhibitor-induced improvement of urinary albumin excretion in non-diabetic, microalbuminuric subjects

Autor: Fal Van der Horst, Wiek H. van Gilst, Ruud M.A. van de Wal, Wim B. M. Gerritsen, Adriaan A. Voors, Pim van der Harst, Thijs H. W. Plokker, Ron T. Gansevoort

Publikováno v: Journal of the Renin-Angiotensin-Aldosterone System, 8(4), 177-180
Journal of the Renin-Angiotensin-Aldosterone System, Vol 8 (2007)

Introduction. Elevated plasma matrix metalloproteinase-9 (MMP-9) levels have been suggested to precede the development of microalbuminuria. As angiotensin-converting enzyme (ACE) inhibitors effectively reduce urinary albumin excretion (UAE), in the p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59c48d4721838ad36219cb819abd9696
https://research.rug.nl/en/publications/c23b0a48-84cf-4ad2-95de-22aa7fa852ec